Litz H Van Dyke

Insider

First SEC filing: March 3, 2011 · Latest: March 3, 2011

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.
Compensation Executive pay disclosed in company proxy statements.

Insider at

CARE buying May 1, 2023

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 29 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

29 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
June 30, 2026	CARE	A	12,300	—	—	79,767 Direct	+18.23%	Acquired	(price as of 2026-08-20)
March 4, 2026	CARE	F	819	$20.98	$17,183	67,467 Direct	-1.20%	Disposed	44.9% (price as of 2026-08-20)
Feb. 25, 2026	CARE	A	4,870	—	—	61,088 Direct	+8.66%	Acquired	(price as of 2026-08-20)
Feb. 25, 2026	CARE	A	7,198	—	—	68,286 Direct	+11.78%	Acquired	(price as of 2026-08-20)
Feb. 14, 2026	CARE	F	1,158	$22.01	$25,488	56,218 Direct	-2.02%	Disposed	38.1% (price as of 2026-08-20)
March 4, 2025	CARE	A	5,442	—	—	57,376 Direct	+10.48%	Acquired	(price as of 2026-08-20)
Feb. 27, 2025	CARE	A	8,279	—	—	53,737 Direct	+18.21%	Acquired	(price as of 2026-08-20)
Feb. 14, 2025	CARE	F	838	$17.99	$15,076	52,899 Direct	-1.56%	Disposed	69.0% (price as of 2026-08-20)
Feb. 20, 2024	CARE	F	249	$13.83	$3,444	52,650 Direct	-0.47%	Disposed	119.8% (price as of 2026-08-20)
Feb. 14, 2024	CARE	F	716	$13.78	$9,866	51,934 Direct	-1.36%	Disposed	120.6% (price as of 2026-08-20)
Jan. 5, 2024	CARE	A	6,012	—	—	45,458 Direct	+15.24%	Acquired	(price as of 2026-08-20)
May 1, 2023	CARE	P	2,200	$13.32	$29,304	39,446 Direct	+5.91%	Acquired	128.3% (price as of 2026-08-20)
Feb. 14, 2023	CARE	A	7,023	—	—	37,246 Direct	+23.24%	Acquired	(price as of 2026-08-20)
July 14, 2022	CARE	P 10b5-1	76	$13.03	$990	30,223 Direct	+0.25%	Acquired	133.3% (price as of 2026-08-20)
June 14, 2022	CARE	P 10b5-1	73	$13.60	$993	30,147 Direct	+0.24%	Acquired	123.6% (price as of 2026-08-20)
May 3, 2022	CARE	P	1,000	$16.00	$16,000	30,074 Direct	+3.44%	Acquired	90.0% (price as of 2026-08-20)
March 7, 2022	CARE	A	6,373	—	—	29,074 Direct	+28.07%	Acquired	(price as of 2026-08-20)
Feb. 19, 2022	CARE	F	243	$16.34	$3,971	22,701 Direct	-1.06%	Disposed	86.1% (price as of 2026-08-20)
Feb. 17, 2022	CARE	A	6,104	—	—	24,795 Direct	+32.66%	Acquired	(price as of 2026-08-20)
Feb. 17, 2022	CARE	F	1,851	$16.03	$29,672	22,944 Direct	-7.47%	Disposed	89.7% (price as of 2026-08-20)
Dec. 14, 2021	CARE	P 10b5-1	68	$14.66	$997	18,691 Direct	+0.37%	Acquired	107.4% (price as of 2026-08-20)
Oct. 14, 2021	CARE	P 10b5-1	66	$14.80	$977	18,623 Direct	+0.36%	Acquired	105.4% (price as of 2026-08-20)
June 1, 2021	CARE	P 10b5-1	129	$15.41	$1,988	18,557 Direct	+0.70%	Acquired	97.3% (price as of 2026-08-20)
May 3, 2021	CARE	P 10b5-1	150	$13.20	$1,980	18,428 Direct	+0.82%	Acquired	130.3% (price as of 2026-08-20)
April 1, 2021	CARE	P 10b5-1	143	$13.95	$1,995	18,278 Direct	+0.79%	Acquired	118.0% (price as of 2026-08-20)
March 1, 2021	CARE	P 10b5-1	161	$12.27	$1,975	18,135 Direct	+0.90%	Acquired	147.8% (price as of 2026-08-20)
Feb. 19, 2021	CARE	A	2,418	$10.92	$26,405	17,974 Direct	+15.54%	Acquired	178.4% (price as of 2026-08-20)
Feb. 1, 2021	CARE	P 10b5-1	198	$10.04	$1,988	15,556 Direct	+1.29%	Acquired	202.8% (price as of 2026-08-20)
Jan. 4, 2021	CARE	P 10b5-1	186	$10.64	$1,979	15,358 Direct	+1.23%	Acquired	185.8% (price as of 2026-08-20)
Dec. 1, 2020	CARE	P 10b5-1	200	$9.90	$1,980	15,172 Direct	+1.34%	Acquired	207.1% (price as of 2026-08-20)
March 1, 2011	1036070	A	1,510	$14.90	$22,499	30,072 Direct	+5.29%	Acquired
March 1, 2011	1036070	A	3,775	$14.90	$56,248	28,562 Direct	+15.23%	Acquired
Feb. 23, 2010	1036070	A	3,726	—	—	24,511 Direct	+17.93%	Acquired
Sept. 8, 2009	1036070	A	3,250	—	—	20,720 Direct	+18.60%	Acquired
Aug. 19, 2009	1036070	S	2,158	$14.30	$30,859	17,422 Direct	-11.02%	Disposed
April 1, 2008	1036070	A	15,571	$16.64	$259,101	40,563 Direct	+62.30%	Acquired
Jan. 16, 2007	1036070	A	9,005	—	—	9,005 Direct	—	Acquired
March 3, 2006	1036070	P	1,300	$41.13	$53,469	2,739 Direct	+90.34%	Acquired
March 2, 2006	1036070	A	6,532	—	—	6,532 Direct	—	Acquired
July 15, 2005	1036070	A	1,704	$34.75	$59,214	4,126 Direct	+70.36%	Acquired
July 15, 2005	1036070	A	572	$34.75	$19,877	1,439 Direct	+65.97%	Acquired
April 22, 2005	1036070	A	500	$33.73	$16,865	867 Direct	+136.24%	Acquired
Oct. 8, 2004	1036070	A	2,422	$32.88	$79,635	2,422 Direct	—	Acquired
Oct. 8, 2004	1036070	A	367	$32.88	$12,067	367 Direct	-50.00%	Disposed

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
April 1, 2008	1036070	Employee Stock Options	Common Stock (15,571)	$19.29	Oct. 1, 2013	15,571	Acquired
Jan. 16, 2007	1036070	Employee Stock Options	Common Stock (9,005)	$31.65	July 16, 2012	9,005	Acquired
March 2, 2006	1036070	Employee Stock Options	Common Stock (6,532)	$42.13	Sept. 1, 2011	6,532	Acquired
July 15, 2005	1036070	Employee Stock Options	Common Stock (1,704)	$34.75	Jan. 1, 2016	1,704	Acquired
Oct. 8, 2004	1036070	Employee Stock Options	Common (2,422)	$32.88	Oct. 8, 2014	2,422	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

CARE

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2025	$703,114	$122,648	—	—	$183,300	—	$46,767	$1,355,859
2024	$676,847	$90,623	—	—	$237,313	—	$44,813	$1,307,912
2023	$644,618	$96,863	—	—	—	—	$43,149	$784,630

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.